Canntab Therapeutics Company Profile, Contacts & Intelligence

Pharmaceutical ManufacturingMarkham, Ontario, Ca12 employeesPILLFounded 2016
2 contacts with email or phone data2 with email data
View verified contacts Compare competitors
Employees
12
Company source estimate
Reachable Contacts
2
Visible contacts with email or phone data
Contacts With Email
2
2 of 4 visible contacts
Departments
3
Mapped contact coverage

Canntab Therapeutics Overview

Traded on the CSE under the ticker PILL. We have developed a product line of solid oral dose delivery systems including extended release (XR), flash melt, immediate release, modified release and bi-layered tablet solutions that provide a variety of cannabinoid and terpenoid blends in exacting dosages. A clear and sustainable competitive advantage with 13 patents pending. Working with Emblem Corp. in Canada and leveraging our joint venture with Queensland Bauxite to market in Australia and Asia, Canntab Therapeutics will be perfectly positioned in the growing wellness market. Two of our products having already received an NPN number from Health Canada. With the help of Lorne Gertner and other we intend to open up markets around the world and as Mr. Gertner says, “I believe the ultimate solution to the delivery of Cannabis will be through a hard pill.” We understand the growing cannabis health and wellness market and are positioned as the premier solution for medical oral dose administration. Safe, discreet, accurate and reliable. Lead by a team of professionals with the experience needed to bring these products to market.

Headquarters
Markham, Ontario, Ca
Website
canntab.ca
Industry
Pharmaceutical Manufacturing
Founded
2016
Stock Symbol
PILL
NAICS
Pharmaceutical and Medicine Manufacturing, Medicinal and Botanical Manufacturing
Phone Number
Available in AeroLeads
Company Email
Available in AeroLeads
Montréal

Canntab Therapeutics Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

2 contacts with contact data
2 with email data in the visible sample.
3 departments represented
Visible contacts with email or phone data are mapped to these departments.
1 company-domain email
Visible contacts using Canntab Therapeutics's company email domain.
Executive
1
Operations
1
General
1

Canntab Therapeutics People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

L
Laxminarayan Joshi
Chief Scientific Officer at Canntab
E
S
Sowmya Billanuka
Qc Laboratory Technician at Canntab
M
Mohammed Zamiruddin
Consultant Scientist at Canntab
E
R
Richard Goldstein
President of First Republic Capital

Canntab Therapeutics Workforce Composition

Seniority breakdown across 9 visible profiles.

Executive
5
Individual contributor
2
VP / Head
1
Associate / junior
1

Compare Similar Companies to Canntab Therapeutics

Explore companies in related markets and compare their industry and employee estimates.

Company Industry / match Employee estimate Page
GSK Pharmaceutical Manufacturing 90.45K View company
Apotex Inc. Pharmaceutical Manufacturing 6.31K View company
Cameco Corporation Mining 2.35K View company
LAPORTE Engineering Services 506 View company
AtomVie Global Radiopharma Inc. Pharmaceutical Manufacturing 137 View company
Neo Performance Materials Chemical Manufacturing 121 View company
Mint Pharmaceuticals Pharmaceutical Manufacturing 89 View company
Nutralab Canada Corp. Pharmaceutical Manufacturing 62 View company
Nanz Pharma Pharmaceutical Manufacturing 49 View company
First Republic Capital Financial Services 5 View company